BIOZ.COM SYSTEM

K974725 · Cardiodynamics International Corp. · DSB · Mar 18, 1998 · Cardiovascular

Device Facts

• Record ID: K974725
• Device Name: BIOZ.COM SYSTEM
• Applicant: Cardiodynamics International Corp.
• Product Code: DSB · Cardiovascular
• Decision Date: Mar 18, 1998
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.2770
• Device Class: Class 2

Indications for Use

The BioZ.com Hemodynamic Monitor is intended to monitor a patient's hemodynamic parameters. These parameters include: ECG, Heart Rate, Pre-ejection Period, Left Ventricular Ejection Time, Systolic Time Ratio, Stroke Volume, Cardiac Output, Cardiac Index, Systemic Vascular Resistance, End Diastolic Volume, End Diastolic Index, Index of Contractility, Acceleration Index, Left Cardiac Work, Thoracic Fluid Content, Respiration Rate.

Device Story

BioZ.com Hemodynamic Monitor is a portable, computer-based system for noninvasive hemodynamic monitoring via thoracic electrical bioimpedance (TEB). System inputs include patient demographics (gender, frame size, height, weight, age, blood pressure) and electrical signals from 8 electrodes placed on the neck and thorax. Device injects minimal current and measures returning voltage waveforms. Proprietary DSP circuitry and software process these inputs to calculate hemodynamic parameters (e.g., Cardiac Output, Stroke Volume, SVR). Used in hospitals, outpatient, and clinical settings by healthcare providers. Output displayed on integrated flat-panel screen; provides real-time monitoring, diagnostic, and trending data. Supports data transmission to hospital monitoring systems. Benefits include noninvasive assessment of cardiovascular status to assist clinical decision-making.

Clinical Evidence

Bench testing only. Accuracy and equivalency protocol compared BioZ.com to BioZ Portable using digitized patient waveforms. Measurements and calculations achieved expected results.

Technological Characteristics

Portable computer-based system; Intel 80X86 processor; proprietary DSP circuitry and firmware. TEB sensing principle using 8 electrodes. Integrated flat-panel display (320x240). Connectivity via hospital monitoring system protocols. Power: AC or internal rechargeable battery. Software: Proprietary DSP algorithms for hemodynamic parameter calculation.

Indications for Use

Indicated for monitoring hemodynamic parameters in patients in hospital, outpatient, and clinical settings. No specific age or gender restrictions provided.

Regulatory Classification

Identification

An impedance plethysmograph is a device used to estimate peripheral blood flow by measuring electrical impedance changes in a region of the body such as the arms and legs.

Special Controls

*Classification.* Class II (special controls). The device, when it is a body composition analyzer which is not intended to diagnose or treat any medical condition, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

Predicate Devices

• CardioDynamics BioZ Portable System (K972320)

Submission Summary (Full Text)

{0}------------------------------------------------

MAR | 8 1998

K974725

### SECTION 2 -- SUMMARY AND CERTIFICATION

#### A. 510(K) SUMMARY

### SUBSTANTIAL EQUIVALENCE:

Identification of predicate device, model and manufacturer:

Predicate device: CardioDynamics BioZ Portable System

BZ - 125 Model:

ﻣﺤﻤﺴﺴﺴ

Manufacturer: CardioDynamics International, Corp.

Predicate device 510(k) # K972320

Reason For Submission: Device Modification -- Repackaging

The BioZ.com System is substantially equivalent to its predicate device, the CardioDynamics BioZ Portable System currently being marketed by CardioDynamics International Corp. The justification for this substantial equivalence determination is presented below.

The BioZ.com System is substantially equivalent to the CardioDynamics BioZ Portable System in terms of design. intended use and principals of operation. Both systems are portable in design and for use in the hospital, outpatient and clinical settings. The intended use of each systems is to noninvasively measure a patients hemodynamic parameters using thoracic electrical bioimpedance (TEB). Monitoring is accomplished by attaching 8 electrodes to the patient (two on each side of the neck and thorax) and injecting a minimal current through the upper electrodes and reading the returning voltage waveform from the inner electrodes.

Since both systems use the same CardioDynamics proprietary DSP circuitry and software, the formulas and algorithms used to calculate the various hemodynamic parameters are essentially the same. In addition, all required input parameters are the same, including patient gender, body frame size, height, weight, age and blood pressure.

The BioZ Portable System and the BioZ.com System are self-contained computer-based products utilizing the same CardioDynamics proprietary DSP circuitry and software. Each system consists of the following components:

1. Instrument:

- A. CardioDynamics proprietary DSP and Patient Interface Circuitry
- B. Intel 80X86 Processor Board
- C. CardioDynamics proprietary DSP firmware and user software
- D. Condor Medical grade power supply
- E. Built in flat-panel screen
- F. Keyboard/keypad
- G. Power Cord
- 2. Patient Cable
- 3. Electrodes/Transducers

{1}------------------------------------------------

The key differences between the two devices are that the CardioDynamics BioZ Portable is based on an off-the-shelf (Dolch brand) PC based system utilizing a full QWERTY keyboard, while the BioZ.com is a CDIc-proprietary platform with built-in keypad and screen (a QWERTY keyboard is an optional accessory). In addition, the BioZ Portable operates exclusively on AC power while the BioZ.com can operate from AC power or from an internal rechargeable battery for limited patient transport use. Although the CardioDynamics proprietary DSP circuitry used in both devices is the same, partitioning changes were made to the boards used in the BioZ com to accommodate the plastic enclosure and different Intel 80X86 family processor chip. The BioZ.com also provides a user-selectable option of a secondary equation for the calculation of the Stroke Volume parameter (Bernstein) in addition to the single Sramek-Bernstein equation in the BioZ portable.

Screen differences were required to accommodate the 320 x 240 dot display of the BioZ.com rather than the 640 x 480 dot display in the BioZ Portable. Screen differences between the BioZ Portable and the BioZ.com include:

- While the BioZ System offered the Patient Data Entry, Monitoring, Indexed Data, 1. Therapeutic, Indexed Therapeutic, Diagnostic, Interactive Trending and Trending Screens, the BioZ.com System will offer only the Patient Data Entry, Monitoring, Therapeutic, Diagnostic and Trending Screens. User configuration of the Monitoring, Diagnostic, and Trending screen in the BioZ.com makes the additional screens unnecessary.
- On many of the BioZ Portable Screens, 7 to 10 parameters were shown at any given 2. time. The BioZ.com System will display up to 5 parameters at a time.
- The parameters shown on the individual BioZ Portable screens were pre-set and could 3. not be changed. The BioZ.com System Monitoring, Diagnostic and Trending Screens can be configured to display a set number of the following parameters:

| ECG | Heart Rate |
|------------------------|--------------------------------------|
| Pre-ejection Period | Left Ventricular Ejection Time |
| Systolic Time Ratio | Stroke Volume |
| Cardiac Output | Cardiac Index |
| End Diastolic Volume | Systemic Vascular Resistance |
| Left Cardiac Work | Systemic Vascular Resistance indexed |
| End Diastolic Index | Index of Contractility |
| Acceleration Index | Left Cardiac Work Index |
| Thoracic Fluid Content | Respiration Rate |

- 4. The Monitoring Screen in the BioZ.com can be configured to display any two of the following waveforms: Impedance, ECG, ΔZ, dZ/dT, Pacer Impulse, Spike Enhanced ECG and/or no waveform. The BioZ Portable always showed ECG, with a user option for a second waveform of either ΔZ or dZ/dT.

{2}------------------------------------------------

- The Waveform Screen is new to the BioZ.com. The screen will show the five 6. parameters selected by the user for the Monitoring Screen along with larger and longer displays of two of the waveforms available in the Monitoring Screen.
- 7. In the BioZ.com System software, there are a number of default values such as CVP, PAOP, height and weight units, automatic data save timing, etc. The user will be able to change the default values within the BioZ.com Software. The BioZ Portable had limited user control over default values.

Another difference between the BioZ Portable and the BioZ.com System is that the BioZ Portable was able to receive external data from two blood pressure devices and one pulse oximeter. The BioZ.com System will be able to receive and transmit data to many common hospital monitoring systems, using their established, documented protocols.

To demonstrate that the two systems are functionally equivalent, an Accuracy and Equivalency Test was performed comparing the CardioDynamics BioZ.com System to the CardioDynamics BioZ Portable The purpose of the protocol was to demonstrate that the BioZ.com System is substantially equivalent to the CardioDynamics BioZ Portable System. Digitized waveforms from a number of patients with various clinical conditions were input into the BioZ Portable System and then the BioZ.com System. After one minute, three parameters were recorded for each device. The measurement and calculations performed by the device achieved the expected results.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. In the center of the seal is a stylized image of an eagle with its wings spread.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 18 1998

Mr. Dennis G. Hepp Chief Technology Officer CardioDynamics International Corp. 6175 Nancy Ridge Drive, Suite 300 San Diego, CA 92121

- K974725 Re: BIOZ.COM SYSTEM II (two) Requlatory Class: Product Code: 74 DSB December 18, 1997 Dated: December 23, 1997 Received:
Dear Mr. Hepp:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labelinq, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{4}------------------------------------------------

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial in your of your device to a legally marketed predicate device equits in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Thomas J. Callahon

Thomas J. Callahan, Ph. D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

# 510(k) Number (if known):

Device Name: BioZ.com Hemodynamic Monitor

## Indications for Use:

The BioZ.com Hemodynamic Monitor is intended to monitor a patient's hemodynamic parameters. These parameters include:

| ECG | Heart Rate |
|------------------------------|--------------------------------|
| Pre-ejection Period | Left Ventricular Ejection Time |
| Systolic Time Ratio | Stroke Volume |
| Cardiac Output | Cardiac Index |
| Systemic Vascular Resistance | End Diastolic Volume |
| End Diastolic Index | Index of Contractility |
| Acceleration Index | Left Cardiac Work |
| Thoracic Fluid Content | Respiration Rate |

(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED)

______________________________________________________________________________________________________________________________________________________________________________

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

______________________________________________________________________________________________________________________________________________________________________________

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

______________________________________________________________________________________________________________________________________________________________________________

Concurrence of CDRH, Office of Device Evaluation (ODE)

| (Division Sign-Off) | |
|-------------------------------------------------------------------|--|
| Division of Cardiovascular, Respiratory, and Neurological Devices | |
| 510(k) Number | |

| Prescription Use | <div style="display:inline-block;">✓</div> | OR | Over-The-Counter Use | |
|----------------------|--------------------------------------------|----|----------------------|--|
| (PER 21 CFR 801.109) | | | | |

(Optional Format 1-2-96)